1. Home
  2. NUAI vs CTMX Comparison

NUAI vs CTMX Comparison

Compare NUAI & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Era Energy & Digital Inc.

NUAI

New Era Energy & Digital Inc.

HOLD

Current Price

$4.40

Market Cap

633.1M

Sector

Energy

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

642.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUAI
CTMX
Founded
N/A
2008
Country
United States
United States
Employees
5
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
633.1M
642.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
NUAI
CTMX
Price
$4.40
$3.76
Analyst Decision
Buy
Strong Buy
Analyst Count
1
10
Target Price
$11.00
$12.10
AVG Volume (30 Days)
9.5M
5.3M
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.61
P/E Ratio
N/A
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$1.72
52 Week High
$9.45
$8.21

Technical Indicators

Market Signals
Indicator
NUAI
CTMX
Relative Strength Index (RSI) 39.66 57.67
Support Level $3.71 $3.40
Resistance Level $5.31 $3.90
Average True Range (ATR) 0.70 0.25
MACD -0.21 0.08
Stochastic Oscillator 6.85 75.23

Price Performance

Historical Comparison
NUAI
CTMX

About NUAI New Era Energy & Digital Inc.

New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: